FDA Panel Agrees GSK’s RSV Vaccine Is Effective But Wants More Data Before Approval

 
• By Brenda Sandburg
RSV vaccine
Advisory committee votes in support of GSK's RSV vaccine for older adults but wants US FDA to delay approval • Source: Shutterstock

More from US FDA Performance Tracker

More from Regulatory Trackers